VYOME HOLDINGS, INC.

HIND ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014
Operating Activities
Net Income $-34.8M $-20.5M $-15.6M $-9.9M
Depreciation & Amortization $330.0K $192.0K $167.0K $166.0K
Depreciation $330.0K
Amortization
Stock-Based Compensation $3.2M $563.0K $207.0K $185.0K
Net Cash from Operating Activities $-30.6M $-19.4M $-11.4M $-9.9M
Investing Activities
Capital Expenditures $1.0M $352.0K $139.0K $268.0K
Business Acquisitions
Net Cash from Investing Activities $-21.9M $6.2M $2.8M $-7.9M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $613.0K $82.8M $5.1M $22.2M
Net Change in Cash $-51.9M $69.6M $-3.5M $4.4M
Free Cash Flow $-31.7M $-19.7M $-11.5M $-10.2M
← Newer Page 2 of 2 Older →